Israel
# |
Name |
Net Income |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 23.92 M
|
Dec. 31, 2023 | USD 5.51 | -1.08% |
|
Israel |
|
2 |
USD 14.01 M
|
Dec. 31, 2023 | USD 20.06 | -0.66% |
|
Israel |
|
3 |
USD 8.28 M
|
Dec. 31, 2023 | USD 7.30 | -3.84% |
|
Israel |
|
4 |
USD 5.17 M
|
Dec. 31, 2023 | USD 2.04 | NA |
|
Israel |
|
5 |
USD 4.45 M
|
Dec. 31, 2023 | USD 6.13 | 0.95% |
|
Israel |
|
6 |
USD 391.63 K
|
Dec. 31, 2023 | USD 0.09 | -4.99% |
|
Israel |
|
7 |
USD 105.48 K
|
Dec. 31, 2023 | USD 0.08 | 0.04% |
|
Israel |
|
8 |
USD -588.25
|
Dec. 31, 2023 | USD 0.54 | -5.79% |
|
Israel |
|
9 |
USD -1.78 K
|
Dec. 31, 2023 | USD 0.02 | 1.63% |
|
Israel |
|
10 |
USD -3.84 K
|
Dec. 31, 2023 | USD 0.00 | -99.04% |
|
Israel |
|
11 |
USD -19.88 K
|
Dec. 31, 2023 | USD 0.02 | -1.36% |
|
Israel |
|
12 |
USD -580.56 K
|
Dec. 31, 2023 | USD 0.73 | -4.24% |
|
Israel |
|
13 |
USD -1.07 M
|
Dec. 31, 2023 | USD 0.20 | -2.14% |
|
Israel |
|
14 |
USD -1.19 M
|
Dec. 31, 2023 | USD 1.20 | 0.92% |
|
Israel |
|
15 |
USD -1.56 M
|
Dec. 31, 2023 | USD 2.58 | -3.90% |
|
Israel |
|
16 |
USD -1.87 M
|
Dec. 31, 2023 | USD 1.21 | 0.04% |
|
Israel |
|
17 |
USD -1.90 M
|
Dec. 31, 2023 | USD 0.19 | -0.67% |
|
Israel |
|
18 |
USD -1.90 M
|
Dec. 31, 2023 | USD 3.80 | 0.26% |
|
Israel |
|
19 |
USD -2.89 M
|
Dec. 31, 2023 | USD 0.84 | 0.91% |
|
Israel |
|
20 |
USD -3.16 M
|
Dec. 31, 2023 | USD 0.20 | 2.02% |
|
Israel |
|
21 |
USD -3.32 M
|
Dec. 31, 2023 | USD 4.33 | 4.29% |
|
Israel |
|
22 |
USD -3.91 M
|
Dec. 31, 2023 | USD 0.19 | 2.52% |
|
Israel |
|
23 |
USD -4.20 M
|
Dec. 31, 2023 | USD 4.83 | -0.52% |
|
Israel |
|
24 |
USD -4.25 M
|
Dec. 31, 2023 | USD 0.51 | 17.58% |
|
Israel |
|
25 |
USD -4.47 M
|
Dec. 31, 2023 | USD 0.19 | 1.64% |
|
Israel |
|
26 |
USD -5.24 M
|
Dec. 31, 2023 | USD 0.87 | 0.07% |
|
Israel |
|
27 |
USD -5.29 M
|
Dec. 31, 2023 | USD 0.07 | 0.45% |
|
Israel |
|
28 |
USD -6.50 M
|
Dec. 31, 2023 | USD 3.44 | 0.58% |
|
Israel |
|
29 |
USD -6.72 M
|
Dec. 31, 2023 | USD 19.02 | 3.99% |
|
Israel |
|
30 |
USD -6.91 M
|
Dec. 31, 2023 | USD 2.82 | -2.08% |
|
Israel |
|
31 |
USD -7.02 M
|
Dec. 31, 2023 | USD 3.84 | -2.29% |
|
Israel |
|
32 |
USD -7.06 M
|
Dec. 31, 2023 | USD 2.73 | -8.00% |
|
Israel |
|
33 |
USD -7.14 M
|
Dec. 31, 2023 | USD 0.51 | -4.99% |
|
Israel |
|
34 |
USD -7.17 M
|
Dec. 31, 2023 | USD 2.26 | -2.59% |
|
Israel |
|
35 |
USD -7.63 M
|
Dec. 31, 2023 | USD 0.01 | 0.04% |
|
Israel |
|
36 |
USD -7.86 M
|
Dec. 31, 2023 | USD 0.04 | -0.60% |
|
Israel |
|
37 |
USD -8.28 M
|
Dec. 31, 2023 | USD 4.46 | 11.46% |
|
Israel |
|
38 |
USD -8.89 M
|
Dec. 31, 2023 | USD 2.36 | -1.67% |
|
Israel |
|
39 |
USD -9.34 M
|
Dec. 31, 2023 | USD 2.74 | -3.52% |
|
Israel |
|
40 |
USD -10.09 M
|
Dec. 31, 2023 | USD 0.09 | -0.28% |
|
Israel |
|
41 |
USD -10.11 M
|
Dec. 31, 2023 | USD 1.03 | -0.96% |
|
Israel |
|
42 |
USD -11.57 M
|
Dec. 31, 2023 | USD 0.52 | -0.27% |
|
Israel |
|
43 |
USD -14.65 M
|
Dec. 31, 2023 | USD 1.24 | 5.08% |
|
Israel |
|
44 |
USD -16.86 M
|
Dec. 31, 2023 | USD 1.56 | -3.11% |
|
Israel |
|
45 |
USD -17.06 M
|
Dec. 31, 2023 | USD 1.65 | -1.71% |
|
Israel |
|
46 |
USD -18.75 M
|
Dec. 31, 2023 | USD 1.85 | 10.75% |
|
Israel |
|
47 |
USD -19.92 M
|
Dec. 31, 2023 | USD 2.67 | 0.76% |
|
Israel |
|
48 |
USD -20.89 M
|
June 30, 2024 | USD 4.33 | -2.68% |
|
Israel |
|
49 |
USD -23.86 M
|
Dec. 31, 2023 | USD 3.09 | 5.46% |
|
Israel |
|
50 |
USD -23.88 M
|
Dec. 31, 2023 | USD 1.59 | 0.10% |
|
Israel |
The Health Care company in Israel with the highest Net Income is RedHill Biopharma Ltd. (NasdaqCM: RDHL) at USD 23.92 M.
The Health Care company in Israel with the lowest Net Income is Teva Pharmaceutical Industries Limited (Tel Aviv Stock Exchange: TEVA.TA) at USD -559.00 M.
The top 10 Health Care companies in Israel by Net Income are RedHill Biopharma Ltd., Ilex Medical Ltd, Kamada Ltd., MIND C.T.I. Ltd, Golden House Ltd, Allmed Solutions Ltd, Bio-View Ltd, Beeio Honey Ltd, XTL Biopharmaceuticals Ltd. and Sonovia Ltd..
The bottom 10 Health Care companies in Israel by Net Income are Teva Pharmaceutical Industries Limited, Nano-X Imaging Ltd., BioLineRx Ltd., Alpha Tau Medical Ltd., Enlivex Therapeutics Ltd., Tikun Olam-Cannbit Pharmaceuticals Ltd, Chemomab Therapeutics Ltd., Evogene Ltd., PolyPid Ltd. and Pluri Inc..